Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

BECLOMETHASONE DIPROPIONATE

All products: general benefit

Other products in the same Health Canada class (R01AD) — coverage varies; not interchangeable

  • Budesonide (Rhinocort Aqua): general benefit, Not a benefit
  • Azelastine + fluticasone (Dymista): not a benefit
  • Fluticasone (Flonase): not a benefit
  • Mometasone furoate (Nasonex): not a benefit
  • Triamcinolone acetonide (Nasacort AQ): not a benefit

Apo-Beclomethasone Nasal Spray · DIN 02238796 · 50mcg · Nas-Sp-200 Dose Pk

General benefitMarketed · checked 2026-09-20
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Beclomethasone Nasal Spray · DIN 02238796 Manufacturer: Apotex Inc.; listing date 2020-07-31 Health Canada: Marketed since 1998-10-07 · brand APO-BECLOMETHASONE NASAL SPRAY · ATC R01AD01 BECLOMETHASONE · form Suspension · route Nasal · ingredients BECLOMETHASONE DIPROPIONATE 50 MCG/ACT · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Beclomethasone Nasal Spray: Formulary list price $12.2600/unit (unit not stated in source; not the patient's cost)

Ministry pays: $12.2600 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=62232 · Verify on the e-Formulary ↗ (DIN 02238796)

Source record
DIN 02238796: Apo-Beclomethasone Nasal Spray Raw flags: sec3=Y Item: 520800028; group id 589; item number 1546; lccId None; manufacturer id APX Source form: Nas-Sp-200 Dose Pk; strength: 50mcg Recorded listing: General benefit Source prices (unrounded): $12.2600; ministry $12.2600 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02238796 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=62232
Interchangeable products
Beconase Aqueous · DIN 02213702 · not recorded Mylan-Beclo AQ · DIN 02172712 · $12.2600
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (52:08 Anti-Inflammatory Agents) and how they are covered

Matched class: 52:08 Anti-Inflammatory Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DEXAMETHASONE, FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN, FLUOROMETHOLONE, FLUOROMETHOLONE ACETATE, KETOROLAC TROMETHAMINE, LODOXAMIDE TROMETHAMINE Some products covered without a code (check the product listing): BUDESONIDE, PREDNISOLONE ACETATE 52:08 Anti-Inflammatory Agents

BUDESONIDE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 64mcg/Metered Dose, 100mcg/Metered Dose · Nas Sp-120 Dose Pk, Nas Sp-165 Dose Pk

AZELASTINE HCL & FLUTICASONE PROPIONATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 137mcg/Actuation&50mcg/Actuation · Nas-Sp-120 Dose Pk

FLUTICASONE PROPIONATE

· 4 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Actuation · Nas Sp-120 Dose Pk

MOMETASONE FUROATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Dose · Nas Sp-140 Dose Pk

TRIAMCINOLONE ACETONIDE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 55mcg/Metered Dose · Nas Sp-120 Dose Pk (with Preservative)

DEXAMETHASONE

· 2 products · General benefit · strengths: 0.1% · Oph Oint-3.5g Pk, Oph Susp

FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN

· 1 products · General benefit · strengths: 0.02% & 1% · Ot Sol

FLUOROMETHOLONE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

FLUOROMETHOLONE ACETATE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

KETOROLAC TROMETHAMINE

· 3 products · General benefit · strengths: 0.5%, 0.45% w/v · Oph Sol, Oph Sol-0.4mL Vial Pk (Preservative-Free)

LODOXAMIDE TROMETHAMINE

· 1 products · General benefit · strengths: 0.1% · Oph Sol

PREDNISOLONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Oph Susp Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:08 and 2 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors, 52:36 Other Eye, Ear, Nose and Throat Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USES PROPADERM is indicated for all skin conditions where a topical anti-inflammatory steroid is indicated, including psoriasis, eczema, allergic dermatoses, neurodermatitis, seborrhea, intertrigo, lichen simplex, lichen planus, discoid lupus erythematosus and anogenital pruritus. https://pdf.hres.ca/dpd_pm/00059265.PDF PM date: December 10, 2020 Source product: PROPADERM; DIN 02089602; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.